BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hing JX, Mok CW, Tan PT, Sudhakar SS, Seah CM, Lee WP, Tan SM. Clinical utility of tumour marker velocity of cancer antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA) in breast cancer surveillance. Breast 2020;52:95-101. [PMID: 32485607 DOI: 10.1016/j.breast.2020.05.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Yan X, Han L, Zhao R, Fatima S, Zhao L, Gao F. Prognosis value of IL-6, IL-8, and IL-1β in serum of patients with lung cancer: A fresh look at interleukins as a biomarker. Heliyon 2022;8:e09953. [DOI: 10.1016/j.heliyon.2022.e09953] [Reference Citation Analysis]
2 Anoop TM, Joseph P R, Soman S, Chacko S, Mathew M. Significance of serum carcinoembryonic antigen in metastatic breast cancer patients: A prospective study. World J Clin Oncol 2022; 13(6): 529-539 [DOI: 10.5306/wjco.v13.i6.529] [Reference Citation Analysis]
3 Bel'skaya LV, Sarf EA. Prognostic Value of Salivary Biochemical Indicators in Primary Resectable Breast Cancer. Metabolites 2022;12:552. [PMID: 35736486 DOI: 10.3390/metabo12060552] [Reference Citation Analysis]
4 Bel’skaya LV, Sarf EA, Solomatin DV, Kosenok VK. Metabolic Features of Saliva in Breast Cancer Patients. Metabolites 2022;12:166. [DOI: 10.3390/metabo12020166] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Tade RS, Patil PO. Fabrication of Poly-l-lysine-Functionalized Graphene Quantum Dots for the Label-Free Fluorescent-Based Detection of Carcinoembryonic Antigen. ACS Biomater Sci Eng 2021. [PMID: 34967597 DOI: 10.1021/acsbiomaterials.1c01087] [Reference Citation Analysis]
6 Li P, Li W, Xie Z, Zhan H, Deng L, Huang J. A label-free and signal-amplifiable assay method for colorimetric detection of carcinoembryonic antigen. Biotechnol Bioeng 2021. [PMID: 34845724 DOI: 10.1002/bit.28003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Lin LP, Tham SY, Loh HS, Tan MTT. Biocompatible graphene-zirconia nanocomposite as a cyto-safe immunosensor for the rapid detection of carcinoembryonic antigen. Sci Rep 2021;11:22536. [PMID: 34795382 DOI: 10.1038/s41598-021-99498-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Goodwin PJ, Dowling RJO, Ennis M, Chen BE, Parulekar WR, Shepherd LE, Gelmon KA, Whelan TJ, Ligibel JA, Hershman DL, Mayer IA, Hobday TJ, Rastogi P, Rabaglio-Poretti M, Lemieux J, Thompson AM, Rea DW, Stambolic V. Cancer Antigen 15-3/Mucin 1 Levels in CCTG MA.32: A Breast Cancer Randomized Trial of Metformin vs Placebo. JNCI Cancer Spectr 2021;5:pkab066. [PMID: 34485814 DOI: 10.1093/jncics/pkab066] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Shi Y, Zheng W, Ruan X, Wei Y. Simultaneous detection of CA15-3 and PGRMC1 on a microfluidic chip for early diagnosis of breast cancer. Journal of Liquid Chromatography & Related Technologies. [DOI: 10.1080/10826076.2021.1968896] [Reference Citation Analysis]
10 Uygur MM, Gümüş M. The utility of serum tumor markers CEA and CA 15-3 for breast cancer prognosis and their association with clinicopathological parameters. Cancer Treat Res Commun 2021;28:100402. [PMID: 34082362 DOI: 10.1016/j.ctarc.2021.100402] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
11 Piskór BM, Przylipiak A, Dąbrowska E, Sidorkiewicz I, Niczyporuk M, Szmitkowski M, Ławicki S. Plasma Concentrations of Matrilysins MMP-7 and MMP-26 as Diagnostic Biomarkers in Breast Cancer. J Clin Med 2021;10:1436. [PMID: 33916127 DOI: 10.3390/jcm10071436] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
12 Fan Y, Ren X, Liu X, Shi D, Xu E, Wang S, Liu Y. Combined detection of CA15-3, CEA, and SF in serum and tissue of canine mammary gland tumor patients. Sci Rep 2021;11:6651. [PMID: 33758208 DOI: 10.1038/s41598-021-85029-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]